Marrone Bio Innovations

Marrone Bio Innovations (MBI) is dedicated to advancing the pest management industry with effective and environmentally responsible bio-based pest management and plant health products. MBI’s products promote plant health and control weeds, plant diseases and pests in agriculture, turf and ornamental, and water applications. Used around the globe, MBI’s high-performance, competitively-priced solutions help customers improve productivity and profitability, operate more sustainably, and reduce risk in their operations
Company Growth (employees)
Type
Public
HQ
Davis, US
Founded
2006
Size (employees)
86 (est)
Marrone Bio Innovations was founded in 2006 and is headquartered in Davis, US

Key People at Marrone Bio Innovations

Pam Marrone

Pam Marrone

CEO and Founder, Board of Directors
Donald J. Glidewell

Donald J. Glidewell

CFO
Keith Pitts

Keith Pitts

Vice President, Regulatory Affairs

Marrone Bio Innovations Office Locations

Marrone Bio Innovations has an office in Davis
Davis, US (HQ)
2121 Second St.
Davis, US
1540 Drew Ave

Marrone Bio Innovations Metrics

Marrone Bio Innovations Financial Metrics

Revenue (2015)

$9.8 m

Revenue growth (2014-15), %

793%

Gross profit

$545 k

Gross profit margin (2015), %

6%

Net income (2015)

($43.7 m)

Market capitalization (28-Apr-2017)

$43.3 m

Closing share price (28-Apr-2017)

$1.7

Cash (31-Dec-2015)

$19.8 m
Marrone Bio Innovations's current market capitalization is $43.3 m.
Marrone Bio Innovations's revenue was reported to be $9.8 m in FY, 2015
FY, 2013Y, 2014FY, 2015

Revenue

$14.5 m$1.1 m$9.8 m

Revenue growth, %

(92%)793%

Gross profit

$3.8 m$545 k

Gross profit Margin, %

26%6%

Operating expense total

$32.8 m$15.2 m$40 m

EBIT

($29 m)($15.5 m)($39.5 m)

EBIT margin, %

(200%)(1416%)(403%)

Interest expense

$6 m$669 k$2.8 b

Interest income

$49 k$17 k$51 m

Pre tax profit

($28.5 m)($16.2 m)($43.7 b)

Income tax expense

Net Income

($28.5 m)($16.2 m)($43.7 m)
FY, 2013FY, 2014FY, 2015

Cash

$24.5 m$35.3 m$19.8 m

Accounts Receivable

$6.2 m$1.8 m$2.3 m

Inventories

$1.7 m$1.3 m$1.3 m

Current Assets

$58.7 m$54.7 m$36 m

PP&E

$9.4 m$20.2 m$18.4 m

Total Assets

$68.9 m$77.2 m$71.8 m

Accounts Payable

$4.5 m$5.8 m$2 m

Current Liabilities

$11.7 m$31.2 m$12.9 m

Preferred Stock

Additional Paid-in Capital

$147.2 m$193.1 m$201.6 m

Retained Earnings

($105.4 m)($159.8 m)($203.6 m)

Total Equity

$41.8 m$33.2 m($2 m)

Financial Leverage

1.6 x2.3 x-35.5 x
FY, 2013FY, 2014FY, 2015

Net Income

($28.5 m)($16.2 m)($43.7 b)

Depreciation and Amortization

$976 k

Accounts Receivable

($3.4 m)$1.8 m

Inventories

($6.8 m)$1.3 m

Accounts Payable

$1.7 m$5.8 m

Cash From Operating Activities

($34 m)($15.5 m)

Purchases of PP&E

($4 m)

Cash From Investing Activities

($17.7 m)

Long-term Borrowings

($9.4 m)

Cash From Financing Activities

$66.1 m

Marrone Bio Innovations Market Value History

Marrone Bio Innovations Online Presence

Marrone Bio Innovations News

Marrone Bio Innovations Company Life

You may also be interested in